Dan S. Kaufman

Affiliated with

Research Area

Biography

Dan S. Kaufman has not added Biography.
If you are Dan S. Kaufman and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 45	2013
Publication title Cited by 2	2025

Other Publications

Article	Year
Differentiation of embryonic stem cells towards hematopoietic cells: progress and pitfalls. Current opinion in hematology\| PubMed ID: 18536568	2008
Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells. Blood\| PubMed ID: 18621931	2008
Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood\| PubMed ID: 14563647	2004
Mouse and human embryonic stem cell models of hematopoiesis: past, present, and future. BioTechniques\| PubMed ID: 14682061	2003
Efficient transfection of embryonic and adult stem cells. Stem cells (Dayton, Ohio)\| PubMed ID: 15277699	2004
Hematopoietic development of human embryonic stem cells in culture. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 15361661	2005
Hematopoietic development of human embryonic stem cells in culture. Methods in molecular medicine\| PubMed ID: 15492412	2005
Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells. Experimental hematology\| PubMed ID: 15504555	2004
Synergistic use of adult and embryonic stem cells to study human hematopoiesis. Current opinion in biotechnology\| PubMed ID: 16095900	2005
Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair. Experimental hematology\| PubMed ID: 16140145	2005
Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16210613	2005
Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood\| PubMed ID: 16278307	2006
Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Experimental hematology\| PubMed ID: 16338487	2005
Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem cells and development\| PubMed ID: 16433619	2005
Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem cells (Dayton, Ohio)\| PubMed ID: 16456127	2006
Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnology and bioengineering\| PubMed ID: 16547998	2006
Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy. Retrovirology\| PubMed ID: 16623949	2006
Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood\| PubMed ID: 17132724	2007
Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem cells (Dayton, Ohio)\| PubMed ID: 17673526	2007
Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood\| PubMed ID: 17875805	2008
Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 18275894	2008
Hematopoietic development of human embryonic stem cells in culture. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 18370295	2008
Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells. Stem cells and development\| PubMed ID: 18447647	2008
Activation of hypoxic response in human embryonic stem cell-derived embryoid bodies. Experimental biology and medicine (Maywood, N.J.)\| PubMed ID: 18535160	2008
Hematopoietic differentiation of human embryonic stem cells by cocultivation with stromal layers. Current protocols in stem cell biology\| PubMed ID: 18819084	2008
Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity. Blood\| PubMed ID: 19365083	2009
Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19581540	2009
Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood\| PubMed ID: 19652198	2009
Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34(+) cells preferentially develop into endothelial cells. Stem cells (Dayton, Ohio)\| PubMed ID: 19711457	2009
Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function. Experimental hematology\| PubMed ID: 20067819	2010
Use of human embryonic stem cells to understand hematopoiesis and hematopoietic stem cell niche. Current stem cell research & therapy\| PubMed ID: 20214557	2010
Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells. Bone\| PubMed ID: 20601304	2010
Pluripotent stem cell-derived natural killer cells for cancer therapy. Translational research : the journal of laboratory and clinical medicine\| PubMed ID: 20801411	2010
HIF hits Wnt in the stem cell niche. Nature cell biology\| PubMed ID: 20885419	2010
Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. Journal of virology\| PubMed ID: 20962093	2011
Methotrexate supports in vivo selection of human embryonic stem cell derived-hematopoietic cells expressing dihydrofolate reductase. Bioengineered bugs\| PubMed ID: 21468213	2010
Induction of fracture repair by mesenchymal cells derived from human embryonic stem cells or bone marrow. Journal of orthopaedic research : official publication of the Orthopaedic Research Society\| PubMed ID: 21674605	2011
Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 21703975	2012
A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem cells (Dayton, Ohio)\| PubMed ID: 21732493	2011
A synthetic substrate to support early mesodermal differentiation of human embryonic stem cells. Biomaterials\| PubMed ID: 21821284	2011
In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 21822894	2011
Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer. Molecular cancer therapeutics\| PubMed ID: 21862685	2011
Concise review: Cord blood banking, transplantation and induced pluripotent stem cell: success and opportunities. Stem cells (Dayton, Ohio)\| PubMed ID: 22069231	2012
Erythroid-specific expression of Î²-globin from Sleeping Beauty-transduced human hematopoietic progenitor cells. PloS one\| PubMed ID: 22216176	2011
Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells. Circulation research\| PubMed ID: 22723295	2012
Pluripotent stem cells and gene therapy. Translational research : the journal of laboratory and clinical medicine\| PubMed ID: 23353080	2013
Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. Circulation\| PubMed ID: 23371930	2013
RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. Blood\| PubMed ID: 23372166	2013
Engineered Human Embryonic Stem Cell-Derived Lymphocytes to Study In Vivo Trafficking and Immunotherapy. Stem cells and development\| PubMed ID: 23421330	2013
Tu-mor(e) blood cells from human pluripotent stem cells. Blood\| PubMed ID: 23429981	2013
Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy. Stem cells translational medicine\| PubMed ID: 23515118	2013
Mouse Xenograft Model for Intraperitoneal Administration of NK Cell Immunotherapy for Ovarian Cancer. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 27177674	2016
Fibrinogen Induces RUNX2 Activity and Osteogenic Development from Human Pluripotent Stem Cells. Stem cells (Dayton, Ohio)\| PubMed ID: 27331788	2016
Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells. Blood\| PubMed ID: 28533309	2017
Single Cell Resolution of Human Hematoendothelial Cells Defines Transcriptional Signatures of Hemogenic Endothelium. Stem cells (Dayton, Ohio)\| PubMed ID: 29139170	2018
Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy. Stem cells (Dayton, Ohio)\| PubMed ID: 29235195	2018
Advances in the role of the aryl hydrocarbon receptor to regulate early hematopoietic development. Current opinion in hematology\| PubMed ID: 29697485	2018
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity. Cell stem cell\| PubMed ID: 30082067	2018
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells. Seminars in immunopathology\| PubMed ID: 30361801	2019
Development of innate immune cells from human pluripotent stem cells. Experimental hematology\| PubMed ID: 30611869	2019
An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 31396935	2019
Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity. Cell stem cell\| PubMed ID: 32531207	2020
Human induced pluripotent stem cell-derived macrophages ameliorate liver fibrosis. Stem cells (Dayton, Ohio)\| PubMed ID: 34460131	2021
Into the multiverse of gene edited NK cell-based therapeutic strategies. Cell stem cell\| PubMed ID: 34861144	2021
Disease-associated mutations in topoisomerase IIβ result in defective NK cells. The Journal of allergy and clinical immunology\| PubMed ID: 35063500	2022
CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity. Nature communications\| PubMed ID: 35393416	2022
Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy. Blood science (Baltimore, Md.)\| PubMed ID: 35402797	2019
Induced pluripotent stem cell-derived engineered T cells, natural killer cells, macrophages, and dendritic cells in immunotherapy. Trends in biotechnology\| PubMed ID: 36858941	2023
CHMP2A regulates broad immune cell-mediated antitumor activity in an immunocompetent in vivo head and neck squamous cell carcinoma model. Journal for immunotherapy of cancer\| PubMed ID: 38702144	2024
Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic Expansion. Cancer research communications\| PubMed ID: 38757809	2024
Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells. Cell stem cell\| PubMed ID: 38986609	2024
Next-generation macrophages: repolarizing CAR-macrophages against cancer. Blood science (Baltimore, Md.)\| PubMed ID: 39071949	2024